The prequotation disclosure notice contains information that is required to be provided to ASX Limited (ASX) for release to the market in connection with the admission of the official list of, and official quotation of, fully paid ordinary shares in the Company.
View the Pre-Quotation Disclosure Notice.
Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway
September 9, 2025
Highlights Dr Nina Webster appointed as IBX Non-Executive Director, bringing significant clinical development expertise and corporate experienceto the IBX Board ahead of HER2 Breast cancer